100-count-label (100 Count Label)
Loratadine Tablet
Product Images NDC 16571-822
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Loratadine (NDC 16571-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
100ctback (100ctback)
This is a drug label with instructions for use and warnings. It advises the user to consult a doctor before using the drug if they have liver or kidney disease, to avoid overdosing, and to seek medical help if an allergic reaction occurs. Pregnant or breastfeeding women should ask a healthcare professional before use. The drug should be kept out of children's reach, and if overdosed, medical help should be sought. The directions indicate that adults and children over 12 years old should take a maximum of one tablet daily. The product should be stored at 20° - 25° C. The label also lists the product's inactive ingredients and includes a phone number for questions or comments.*
30-count-label (30 Count Label)
30ctback (30ctback)
Not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
